
Lenvima (Lenvatinib)
- « Back to Catalog
-
Lenvima (generic name Lenvatinib) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. Lenvima was developed by Eisai and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
-